DE602004030367D1 - Diagnostikum für osteoporose - Google Patents

Diagnostikum für osteoporose

Info

Publication number
DE602004030367D1
DE602004030367D1 DE602004030367T DE602004030367T DE602004030367D1 DE 602004030367 D1 DE602004030367 D1 DE 602004030367D1 DE 602004030367 T DE602004030367 T DE 602004030367T DE 602004030367 T DE602004030367 T DE 602004030367T DE 602004030367 D1 DE602004030367 D1 DE 602004030367D1
Authority
DE
Germany
Prior art keywords
osteoporosis
diagnostic
haplotype
therapeutics
diagnostics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004030367T
Other languages
English (en)
Inventor
Kenneth Kornman
Paul M Martha
Gordon W Duff
Dijk Simon Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interleukin Genetics Inc
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of DE602004030367D1 publication Critical patent/DE602004030367D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004030367T 2003-08-08 2004-08-09 Diagnostikum für osteoporose Active DE602004030367D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49386103P 2003-08-08 2003-08-08
PCT/US2004/025858 WO2005013809A2 (en) 2003-08-08 2004-08-09 Diagnostic and therapeutics for osteoporosis

Publications (1)

Publication Number Publication Date
DE602004030367D1 true DE602004030367D1 (de) 2011-01-13

Family

ID=34135292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030367T Active DE602004030367D1 (de) 2003-08-08 2004-08-09 Diagnostikum für osteoporose

Country Status (11)

Country Link
US (1) US7723028B2 (de)
EP (1) EP1680513B1 (de)
JP (1) JP2007501627A (de)
KR (1) KR20060061350A (de)
CN (1) CN1863928A (de)
AT (1) ATE490339T1 (de)
AU (1) AU2004263184B2 (de)
CA (1) CA2534365A1 (de)
DE (1) DE602004030367D1 (de)
HK (1) HK1093757A1 (de)
WO (1) WO2005013809A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
JP2007501627A (ja) 2003-08-08 2007-02-01 インタールーキン ジェネティックス インク 骨粗鬆症のための診断法および治療法
EP1951903A2 (de) * 2005-10-25 2008-08-06 Interleukin Genetics, Inc. Der il-1-gencluster und damit assoziierte entzündungspolymorphismen und haplotypen
US8101360B2 (en) * 2006-11-15 2012-01-24 Interleukin Genetics, Inc. IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
KR100909709B1 (ko) * 2007-03-30 2009-07-30 대한민국 골밀도 및 골절 위험과 ｉｔｇａ１ 유전자 다형성과의연관성
US20100112570A1 (en) * 2008-10-22 2010-05-06 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
WO2010083294A2 (en) * 2009-01-16 2010-07-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
JP2019503176A (ja) 2016-01-12 2019-02-07 インターロイキン ジェネティクス， インコーポレイテッド 処置に対する応答を予測するための方法
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
DK0652975T3 (da) 1992-07-31 2005-02-14 Garvan Inst Med Res Vurdering af allelvariation med hensyn til trans-virkende faktorer
JP3472587B2 (ja) 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
DE69333641T2 (de) 1992-12-28 2005-11-03 Baylink, David Jeston, Redlands Methode zur messung der knochenresorption
CA2153387A1 (en) 1993-01-07 1994-07-21 Hubert Koester Dna sequencing by mass spectrometry
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5942390A (en) 1996-01-12 1999-08-24 Cedars-Sinai Medical Center Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9621129D0 (en) * 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
ATE318328T1 (de) * 1999-08-30 2006-03-15 Interleukin Genetics Inc Diagnostika und therapeutika für osteoporose
JP2002345500A (ja) * 2000-12-22 2002-12-03 Pfizer Prod Inc 炎症性障害を発展させる増加したリスクを検出するための方法および試薬
EP1409737A4 (de) * 2001-06-15 2005-10-12 Interleukin Genetics Inc Verfahren zum nachweis und zur behandlung des frühen auftretens von mit dem altern zusammenhängenden beschwerden
JP2007501627A (ja) 2003-08-08 2007-02-01 インタールーキン ジェネティックス インク 骨粗鬆症のための診断法および治療法

Also Published As

Publication number Publication date
HK1093757A1 (en) 2007-03-09
CN1863928A (zh) 2006-11-15
JP2007501627A (ja) 2007-02-01
EP1680513A4 (de) 2006-11-08
EP1680513A2 (de) 2006-07-19
AU2004263184A1 (en) 2005-02-17
EP1680513B1 (de) 2010-12-01
US20050084882A1 (en) 2005-04-21
KR20060061350A (ko) 2006-06-07
CA2534365A1 (en) 2005-02-17
AU2004263184B2 (en) 2010-12-02
US7723028B2 (en) 2010-05-25
WO2005013809A3 (en) 2006-01-12
WO2005013809A2 (en) 2005-02-17
ATE490339T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
HK1093757A1 (en) Diagnostic for osteoporosis
NO20070949L (no) Transkriptomdiagnostikk i spytt
DE602004011755D1 (de) Verriegelungsanordnung für motorhaube
DK1597282T3 (da) Antistofmolekyler, der har specificitet for human IL-1 beta
DE502004012191D1 (de) Antriebsstrang für eine Strömungskraftmaschine
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
DE502005011206D1 (de) Medizinisches Instrument für die Elektrochirurgie
DE602004031818D1 (de) Halbkugelförmiges Ventil für eine medizinische Vorrichtung
DE602004023560D1 (de) Behandlungswerkzeug für ein Endoskop
DE60116365D1 (de) Radiopharmazeutika für die diagnose von alzheimer
TW200644594A (en) Performing diagnostics in a wireless system
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
ITGE20040108A1 (it) Maschera subacquea e metodo per la sua fabbricazione.
DE60202596D1 (de) Schaupackung für z.b. eier
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
DE50301232D1 (de) Skibindung, insbesondere für den langlauf
ATE447628T1 (de) Einzelsequenzhybridisierungssonden
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
NL1023433A1 (nl) Evaluatie van in de tijd veranderlijke diagnostische processen.
DE60321783D1 (de) Fehlerkorrektur für kryptographische Schlüssel
DE502004008685D1 (de) Fadenführervorrichtung für ringspindel
DE602004018819D1 (de) Diagnoseverfahren für malignes Melanom
ES1056145Y (es) Palanca de maniobra del capo de un automovil.